Mundipharma AG 3
3 · Cidara Therapeutics, Inc. · Filed Sep 13, 2019
Insider Transaction Report
Form 3
Mundipharma AG
10% Owner
Holdings
- 4,781,408
Common Stock, $0.0001 par value per share
Footnotes (1)
- [F1]Pursuant to the terms of that certain Stock Purchase Agreement, dated September 3, 2019 (the "Purchase Agreement"), by and between Cidara Therapeutics, Inc., a Delaware corporation (the "Company"), and Mundipharma AG, an entity with its principal place of business in Switzerland (the "Reporting Person"), the Reporting Person purchased from the Company 4,781,408 shares of the Company's common stock, $0.0001 par value per share, for an aggregate purchase price of approximately $9.0 million.